IDIVAL

What IDIVAL does

IDIVAL (Fundación Instituto de Investigación Marqués de Valdecilla) is a Spanish non-profit biomedical research foundation established in 2014 and headquartered in Santander, Cantabria. The institute functions as the dedicated research arm of the Hospital Universitario Marqués de Valdecilla (HUMV) and the broader Servicio Cántabro de Salud (SCS), providing biomedical researchers and clinicians in the Cantabria region with access to clinical trial support, translational research infrastructure, and innovation programmes. Its core offerings include a Clinical Trials Agency (with CEIM ethics committee and contract management), Biobank Valdecilla, Flow Cytometry and Cell Sorting Unit, Microscopy Unit, Metabolomics Unit, and the Biblioteca Marquesa de Pelayo library providing access to major biomedical databases (PubMed, Clinical Key, UpToDate, Ovid, WoS).

The organization operates a platform-plus-modules architecture, with the Portal de Investigación IDIVAL serving as the central gateway for research activity and project management, and the Fund@Net platform handling internal project administration. The PLADIBIO programme functions as the primary funding and talent development framework, distributing more than €1.5 million across eight biomedical research promotion programmes in 2026 covering talent recruitment, innovation, internationalization, and patient-based studies. Innovation activities are channeled through the LINNUX innovation platform, prototyping services, a Public Procurement of Innovation (CPI) programme for patient safety, and the StarVal intrapreneurship programme. The institute holds HRS4R accreditation and participates in European research consortia including JACARDI, CIRCE-JA, IMPaCT Cohort, and EUCanScreen, with EATRIS membership.

IDIVAL is funded primarily through public research grants and subsidies from national and regional government bodies, including the Instituto de Salud Carlos III (ISCIII), the Agencia Estatal de Investigación (AEI), FECYT, the European Commission (Horizon Europe), the Gobierno de Cantabria, and the Fundación Caja Cantabria. Core services are provided at no direct charge to researchers within the Cantabrian public health system, with external researchers and private entities subject to published tariffs (TARIFAS-EC-2017.pdf). The institute employs 101-250 people, operates as an independent legal foundation (CIF G39788773), and has no parent company or venture capital ownership structure. Revenue is not publicly disclosed.

Name

IDIVAL

Legal name

FUNDACIÓN INSTITUTO DE INVESTIGACIÓN MARQUÉS DE VALDECILLA

Website

https://idival.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Short description

IDIVAL is a non-profit biomedical research foundation in Santander, Spain, providing clinical trial support, translational research infrastructure, and innovation programmes to researchers and clinicians within the public healthcare system of Cantabria.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Other Scientific and Technical Consulting Services (54169), Grantmaking and Giving Services (81321), Voluntary Health Organizations (813212)

SIC

Services-Medical Laboratories (8071), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

akta.pro secondary industries

Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Biomedical research
• Clinical trials
• Translational medicine
• Research infrastructure
• Healthcare innovation

Headquarters

HQ city

Santander

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Public Research Grants and Subsidies: IDIVAL operates as a publicly funded biomedical research institute receiving support from national and regional government bodies. The institute distributes research funding through its own calls and programmes including the PLADIBIO programme, which exceeded €1.5 million in 2026 support. Funding comes from entities including Instituto de Salud Carlos III, FECYT, AEI, European Commission, and Fundación Caja Cantabria.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

IDIVAL is a non-profit biomedical research foundation that delivers integrated research infrastructure and clinical trial support services to the public healthcare system of Cantabria. Its offerings combine the PLADIBIO funding programme, a Clinical Trials Agency with ethics oversight, and dedicated Technological Services units (Biobank, Flow Cytometry, Microscopy, Metabolomics), alongside innovation, training, and library services for affiliated researchers.

Product overview

IDIVAL (Instituto de Investigación Marqués de Valdecilla) is a biomedical research institute based in Santander, Spain, operating as a comprehensive research infrastructure for the Cantabria Health System. The organization operates as a platform-plus-modules architecture, combining core research infrastructure services with specialized support programmes. The central hub is the Portal de Investigación IDIVAL, which provides access to all research activities in Cantabria, supported by the PLADIBIO Programme as the primary funding and talent development framework. Core technological capabilities are delivered through dedicated units (Biobank, Flow Cytometry, Microscopy, Metabolomics), while clinical research is supported by the Clinical Trials Agency. Innovation activities are channeled through LINNUX, Prototyping Services, and the Public Procurement of Innovation (CPI) programme. Research support is enhanced by the Biblioteca Marquesa de Pelayo library with access to major biomedical databases, the Boletín IDIVAL newsletter, and Training & Methodology programmes. The institute also operates internal platforms (Fund@Net) for project and knowledge management, all accessible to affiliated researchers through a unified digital ecosystem.

Differentiator

Problem solved

Functional benefit

Brands

• Biblioteca Marquesa de Pelayo: Library service that is part of IDIVAL and supports the Public Health System of Cantabria, located in the Hospital Universitario Marqués de Valdecilla.

Products and services

• PLADIBIO Programme

Quantifiable outcome

• €1.5 million+ allocated to 8 biomedical research promotion programmes in 2026

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

16 partnerships are on record, tiered core.

• Instituto de Salud Carlos III (ISCIII)coreStrategic or Co-development PartnerNational health research institute coordinating national research programmes. IDIVAL participates in ISCIII-coordinated projects including the IMPaCT Cohort study monitoring 200,000 people over 20 years.
• EATRIS (European Research Infrastructure for Translational Medicine)coreStrategic or Co-development PartnerEuropean infrastructure for translational medicine. IDIVAL maintains membership and participates in European research collaboration through this network.
• Universidad de CantabriacoreStrategic or Co-development PartnerRegional public university. IDIVAL collaborates academically and research-wise with the university for biomedical research and training.
• Hospital Universitario Marqués de Valdecilla (HUMV)coreStrategic or Co-development PartnerPrimary teaching hospital of Cantabria. IDIVAL is the research institute associated with this hospital, conducting clinical trials and biomedical research.
• Servicio Cántabro de Salud (SCS)coreStrategic or Co-development PartnerCantabrian Health Service. IDIVAL provides research support services to the public healthcare system of Cantabria.
• Agencia Estatal de Investigación (AEI)coreStrategic or Co-development PartnerSpanish State Research Agency. Supports IDIVAL programmes including talent return programmes (PROGRAMA ATRAE) and expert personnel programmes.
• FECYT (Fundación Española para la Ciencia y la Tecnología)coreStrategic or Co-development PartnerSpanish Foundation for Science and Technology. Provides funding support for scientific communication and dissemination activities.
• European Commission (Horizon Europe)coreStrategic or Co-development PartnerEU funding body for research. IDIVAL participates in European projects under Horizon Europe including Health Cluster 1, MSCA programmes, and collaborative transnational calls.
• Gobierno de CantabriacoreStrategic or Co-development PartnerRegional government of Cantabria. Provides institutional support and funding for biomedical research activities in the region.
• JACARDI (European Cardiovascular Disease Initiative)coreStrategic or Co-development PartnerEuropean project focused on cardiovascular disease. IDIVAL participates in European meetings to promote transfer of results into healthcare systems.
• CIRCE-JA (European Cancer Research Initiative)coreStrategic or Co-development PartnerEuropean cancer research consortium. IDIVAL participates in the third CIRCE-JA Consortium Meeting in Rome as part of international collaboration.
• CIBER (Centro de Investigación Biomédica en Red)coreStrategic or Co-development PartnerBiomedical Research Networking Centres. Coordinates the IMPaCT Cohort study in which IDIVAL participates.
• EUCanScreencoreStrategic or Co-development PartnerEuropean cancer screening initiative. Valdecilla's Digestive Service participates with advanced digestive endoscopy training courses in European centres.
• Cohorte IMPaCTcoreStrategic or Co-development PartnerLarge national health cohort study coordinated by ISCIII through CIBER aiming to monitor 200,000 people in Spain over 20 years. IDIVAL is one of the participating centres.
• HRS4R (Human Resources Strategy for Researchers)coreStrategic or Co-development PartnerEuropean initiative for researchers' working conditions. IDIVAL has obtained HRS4R accreditation demonstrating commitment to excellent research environment.
• Fundación Caja CantabriacoreStrategic or Co-development PartnerRegional savings bank foundation. Provides funding for the annual 'Enfermería Valdecilla' research project call.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Others

• EATRIS (European Research Infrastructure for Translational Medicine): European research infrastructure consortium of which IDIVAL is a member. Comparable as an ecosystem participant — both facilitate translational medicine, multi-country research collaboration, and shared access to advanced biomedical platforms across Europe.
• ISCIII (Instituto de Salud Carlos III): Spain's national health research institute and a key funder/partner of IDIVAL. Comparable as a public-sector biomedical research organizer coordinating national programmes (e.g., IMPaCT Cohort) and distributing public health research funding across Spanish institutions.

Direct peers

• IBIMA (Instituto de Investigación Biomédica de Málaga): Andalusian biomedical research institute integrating multiple hospitals and primary care. Comparable to IDIVAL as a regional hospital-linked research foundation coordinating clinical research, training, and biomedical platforms in a Spanish autonomous community.
• IRB Barcelona: Catalan biomedical research institute focused on fundamental and translational research. Comparable to IDIVAL as a Spanish non-profit research centre delivering biomedical research, training, and international collaboration, although IRB Barcelona operates at a larger national scale.
• Vall d'Hebron Institute of Oncology (VHIO): Oncology-focused research institute embedded in the Vall d'Hebron University Hospital. Directly comparable to IDIVAL in model: hospital-linked research institute conducting clinical trials, translational research, and core facility services for a regional public health system.
• IMIM — Hospital del Mar Medical Research Institute: Biomedical research institute linked to the Hospital del Mar in Barcelona. Comparable to IDIVAL as a Spanish hospital-anchored research foundation delivering biomedical research, clinical trials, and training across a wide range of therapeutic areas.
• IIS La Fe (La Fe Health Research Institute): Research institute associated with Hospital Universitari i Politècnic La Fe in Valencia. Closely comparable to IDIVAL as a non-profit foundation tied to a major Spanish teaching hospital, offering clinical trial support, biobank services, and translational research infrastructure.

Broad incumbents

• CNIC (Centro Nacional de Investigaciones Cardiovasculares): Spain's national cardiovascular research centre. Comparable to IDIVAL as a non-profit biomedical research institution participating in national and EU-funded research, but operating at a much larger national scale with deeper resources and broader reach.
• CNIO (Centro Nacional de Investigaciones Oncológicas): Spain's national cancer research centre. Comparable to IDIVAL as a Spanish non-profit biomedical research institution, but at a national scale with broader cancer specialization, larger infrastructure, and more international visibility.
• Karolinska Institutet: Major Swedish medical university with extensive biomedical research infrastructure. Comparable to IDIVAL as a publicly funded biomedical research institution participating in European research consortia and clinical trials, but at a vastly larger scale and broader international standing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/idivaldecilla

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDIVAL